Andere Sprachen MedMira Inc.

Aktien

932414

CA58501R1029

MIR

Markt geschlossen - Toronto S.E. Andere Börsenplätze 21:15:26 25.06.2024			% 5 Tage	% 1. Jan.
0,075 ^CAD	-6,25 %		-11,76 %	-31,82 %

02.04.	MedMira Inc. meldet Ergebnis für das zweite Quartal und die sechs Monate bis zum 31. Januar 2024	CI
27.03.	Samsung Pay arbeitet ab dem 3. April nicht mehr mit dem russischen Zahlungssystem Mir zusammen	RE

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

MedMira Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	02.04.
Samsung Pay to stop working with Russia's Mir payment system from April 3	27.03.
MedMira Says Received Canadian Patent for its Quantitative Diagnostic System	13.03.
MedMira Brief: Says Received Canadian Patent for its Quantitative Diagnostic System	13.03.
MedMira's Fiscal Q1 Loss Widens, Revenue Drops	02.01.
MedMira Inc. Reports Earnings Results for the First Quarter Ended October 31, 2023	29.12.
U.S. FDA Approves MedMira's Advanced Reveal G4 Rapid HIV-1/2 Antibody Test	14.12.
MedMira Inc. Reports Earnings Results for the Full Year Ended July 31, 2023	28.11.
Medmira Inc. Provides Update on Its Progress to Achieve Regulatory Approval in Canada and the USA for Its Infectious Disease Rapid Tests	28.09.23
Canadian Investment Regulatory Organization Trade Resumption - MIR	31.08.23
Canadian Investment Regulatory Organization Trading Halt - MIR	29.08.23
MedMira's Fiscal Q3 Loss Widens, Revenue Falls	30.06.23
MedMira Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023	29.06.23
MedMira Falls Near 17% As Widens Q2 Net Loss YOY	04.04.23
MedMira Widens Q2 Net Loss YOY	04.04.23
MedMira Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023	03.04.23
MedMira Inc. Provides an Update on Its Progress to Achieve Regulatory Approval in Canada for Its Reveal TP Antibody Test	14.03.23
MedMira Enters into Partnership with Maternova for USA and Latin America	21.02.23
MedMira enters into Partnership with Maternova for USA and Latin America	21.02.23
Maternova and MedMira Enter Distribution Agreement to Market Rapid Diagnostics for HIV, Syphilis and Hepatitis	20.02.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen MedMira Inc.

Aktien

932414

CA58501R1029

MIR

Andere Sprachen

Filter